Gujarat Inject [GUJINJEC] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison

Gujarat Inject (Kerala) Ltd.

BSE
Loading...

Panacea Biotec Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Gujarat Inject (Kerala) Ltd. wins in 12 metrics, Panacea Biotec Ltd. wins in 6 metrics, with 1 ties. Gujarat Inject (Kerala) Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gujarat Inject (Kerala) Ltd. Panacea Biotec Ltd. Better
P/E Ratio (TTM) 158.27 182.62 Gujarat Inject (Kerala) Ltd.
Price-to-Book Ratio 12.63 2.65 Panacea Biotec Ltd.
Debt-to-Equity Ratio 0.00 2.79 Tie
PEG Ratio -2.01 -15.02 Gujarat Inject (Kerala) Ltd.
EV/EBITDA 93.74 -65.87 Gujarat Inject (Kerala) Ltd.
Profit Margin (TTM) 2.51% -1.29% Gujarat Inject (Kerala) Ltd.
Operating Margin (TTM) 2.88% 1.99% Gujarat Inject (Kerala) Ltd.
EBITDA Margin (TTM) 2.88% 1.99% Gujarat Inject (Kerala) Ltd.
Return on Equity 10.16% -1.01% Gujarat Inject (Kerala) Ltd.
Return on Assets (TTM) 8.51% -0.65% Gujarat Inject (Kerala) Ltd.
Free Cash Flow (TTM) $-15.46M $-776.74M Gujarat Inject (Kerala) Ltd.
1-Year Return 425.15% 18.85% Gujarat Inject (Kerala) Ltd.
Price-to-Sales Ratio (TTM) 13.82 3.61 Panacea Biotec Ltd.
Enterprise Value $1.18B $19.26B Panacea Biotec Ltd.
EV/Revenue Ratio 11.69 3.18 Panacea Biotec Ltd.
Gross Profit Margin (TTM) 0.14% 58.88% Panacea Biotec Ltd.
Revenue per Share (TTM) $11 $99 Panacea Biotec Ltd.
Earnings per Share (Diluted) $0.60 $-1.28 Gujarat Inject (Kerala) Ltd.
Beta (Stock Volatility) -0.90 0.14 Gujarat Inject (Kerala) Ltd.

Gujarat Inject (Kerala) Ltd. vs Panacea Biotec Ltd. Stock Performance Analysis

Loading Price Chart...

GUJINJEC
PANACEABIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gujarat Inject (Kerala) Ltd.-1.68%-2.42%13.59%63.41%279.75%225.27%
Panacea Biotec Ltd.0.90%-2.19%39.94%70.71%51.42%43.20%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gujarat Inject (Kerala) Ltd.425.15%1,090.00%3,947.62%3,947.62%3,947.62%3,947.62%
Panacea Biotec Ltd.18.85%307.76%44.67%440.21%276.43%141.23%

Performance & Financial Health Analysis: Gujarat Inject (Kerala) Ltd. vs Panacea Biotec Ltd.

MetricGUJINJECPANACEABIO
Market Information
Market Cap i₹1.38B₹21.84B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i22,292168,211
90 Day Avg. Volume i41,507144,184
Last Close₹117.00₹540.80
52 Week Range₹19.01 - ₹125.50₹292.40 - ₹647.00
% from 52W High-6.77%-16.41%
All-Time High₹125.50 (Jun 09, 2026)₹647.00 (Jun 09, 2026)
% from All-Time High-6.77%-16.41%
Growth Metrics
Quarterly Revenue Growth-0.44%0.01%
Quarterly Earnings Growth-0.82%-0.12%
Financial Health
Profit Margin (TTM) i0.03%-0.01%
Operating Margin (TTM) i0.03%0.02%
Return on Equity (TTM) i0.10%-0.01%
Debt to Equity (MRQ) i0.002.79
Cash & Liquidity
Book Value per Share (MRQ)₹7.52₹134.77
Cash per Share (MRQ)₹0.18₹13.86
Operating Cash Flow (TTM) i₹-31,076,498₹-1,511,860,000
Levered Free Cash Flow (TTM) i₹10.17M₹-83,700,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Gujarat Inject (Kerala) Ltd. vs Panacea Biotec Ltd.

MetricGUJINJEC (Apr 24, 2026)PANACEABIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i158.27182.62
Forward P/E iN/AN/A
PEG Ratio i-2.01-15.02
Price to Sales (TTM) i13.823.61
Price to Book (MRQ) i12.632.65
Market Capitalization
Market Capitalization i₹1.38B₹21.84B
Enterprise Value i₹1.18B₹19.26B
Enterprise Value Metrics
Enterprise to Revenue i11.693.18
Enterprise to EBITDA i93.74-65.87
Risk & Other Metrics
Beta i-0.900.14
Book Value per Share (MRQ) i₹7.52₹134.77

Financial Statements Comparison: Gujarat Inject (Kerala) Ltd. vs Panacea Biotec Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGUJINJEC (2025)PANACEABIO (2025)
Revenue/Sales i190.46M4.93B
Cost of Goods Sold i177.77M2.36B
COGS % of Revenue i93.3%47.9%
Gross Profit i12.68M2.57B
Gross Margin i6.7%52.1%
Research & Development iN/AN/A
Operating Income (EBIT) i10.75M-556.12M
Operating Margin i5.6%-11.3%
EBITDA i12.56M-76.28M
EBITDA Margin i6.6%-1.5%
Pre-Tax Income i12.54M-79.48M
Pre-Tax Income % of Revenue i6.6%-1.6%
Income Tax i2.37M7.71M
Income Tax % of Revenue i1.2%0.2%
Net Income (Profit) i10.17M-87.19M
Profit Margin i5.3%-1.8%

Balance Sheet & Liquidity Metrics

MetricGUJINJEC (2025)PANACEABIO (2025)
Cash & Equivalents i262,785821.25M
Total Current Assets i99.75M5.45B
Total Current Assets % of Revenue i52.4%110.7%
Total Current Liabilities i19.38M3.67B
Total Current Liabilities % of Revenue i10.2%74.5%
Long-Term Debt i0150.00M
Long-Term Debt % of Revenue i0.0%3.0%
Total Shareholders Equity i100.12M8.31B
Retained Earnings iN/A7.80B
Retained Earnings % of Revenue i0.0%158.3%
Property, Plant & Equipment iN/A5.43B

Cash Flow Statement Comparison

MetricGUJINJEC (2025)PANACEABIO (2025)
Operating Cash Flow i-31.08M-1.51B
Operating Cash Flow % of Revenue i-16.3%-30.7%
Capital Expenditures i0-497.30M
Free Cash Flow i-15.46M-776.74M
FCF Margin i-8.1%-15.8%
Debt Repayment i-19.76M0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGUJINJECPANACEABIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i14.65M61.25M
Float Shares i1.00M15.42M
% Held by Insiders i63.90%72.65%
% Held by Institutions i0.00%0.13%
% Held by Public i36.10%27.22%

Dividend Analysis & Yield Comparison: Gujarat Inject (Kerala) Ltd. vs Panacea Biotec Ltd.

MetricGUJINJECPANACEABIO
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A